Amir Reza Jalilian - Cyclotron Department, Nuclear Research Center for Agriculture and Medicine, AEOI, Karaj, Iran
Hossein Afarideh - Cyclotron Department, Nuclear Research Center for Agriculture and Medicine, AEOI, Karaj, Iran
Baratali Akbari - Cyclotron Department, Nuclear Research Center for Agriculture and Medicine, AEOI, Karaj, Iran
Mohammad Shafiei - Cyclotron Department, Nuclear Research Center for Agriculture and Medicine, AEOI, Karaj, Iran
Behrooz Shirazi - Cyclotron Department, Nuclear Research Center for Agriculture and Medicine, AEOI, Karaj, Iran
Mohammad Mirzaii - Cyclotron Department, Nuclear Research Center for Agriculture and Medicine, AEOI, Karaj, Iran
Khosro Ardaneh - Cyclotron Department, Nuclear Research Center for Agriculture and Medicine, AEOI, Karaj, Iran

The use of [۱۸F]-۲-FDG has been increasing in recent years. This agent was originally used for evaluation of CNS glucose uptake and pathologic conditions by positron emission tomography (PET). In view of increasing demand for this agent, its production has been started at cyclotron dept., Nuclear research center for agriculture & Medicine-Karaj Iran (NRCAM). In this paper, [۱۸F]-FDG synthesis, quality control and other technical aspects are discussed.